HALO logo

Halozyme Therapeutics, Inc. (HALO)

Profile

Full Name

Halozyme Therapeutics, Inc.

Ticker

NASDAQ: HALO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 16, 2004

Indexes

Not included

Website

http://halozyme.com

Employees

350

Key Details

Price

$57.15(-0.83%)

Market cap

$7.04B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.02B(+22.44% YoY)

Annual EPS

$3.43(+63.33% YoY)

PE ratio

15.20

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $57.15
    HALO price is $57.15

    30-Day Relative Volume

    0.48
    HALO 30-day relative volume is 0.48

    Price Performance

    Price Most recent change

    -0.83%
    HALO price was down -0.83% on Jul 11, 2025

    Price YTD change

    +19.54%
    HALO price is up +19.54% since January 1st

    Price 1-year change

    +8.2%
    HALO price is up +8.2% year-on-year

    Price 3-year change

    +14.3%
    HALO price is up +14.3% over the past 3 years

    Price Range

    Price All-time high

    $70.51
    HALO price is currently -18.95% below its historical high of $70.51

    Price 3-year low

    $29.85
    HALO price is currently +91.46% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $7.04B
    HALO market capitalization is $7.04 billion

    Market cap 3-year change

    +2.3%
    HALO market capitalization is up +2.3% over the past 3 years

    Market cap All-time high

    $8.64B
    HALO market capitalization is currently -18.52% below its historical high of $8.64 billion

    Market cap sector rank

    90.5%
    HALO market capitalization is higher than 90.5% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -2.62%
    HALO shares outstanding is down -2.62% year-on-year

    Shares Outstanding 3-Year Change

    -10.5%
    HALO shares outstanding is down -10.5% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.64
    HALO beta is 0.64

    200-day SMA

    $55.40
    HALO price is currently +3.17% above its 200-day simple moving average

    50-day SMA

    $55.45
    HALO price is currently +3.06% above its 50-day simple moving average

    RSI

    62.40
    HALO 14-day relative strength index is 62.40

    Volume

    0.48
    HALO 30-day relative volume is 0.48

    ATR

    $1.36
    HALO average true range is $1.36

    10-day Historical Volatility

    19.83%
    HALO 10-day historical volatility is 19.83%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.02B
    HALO annual revenue is $1.02 billion

    Revenue Analysts estimate

    $1.25B
    HALO annual revenue is currently -18.46% lower than the consensus analysts' forecast

    Revenue 1-year change

    +22.44%
    HALO annual revenue is up +22.44% year-on-year

    Revenue Sector rank

    80.07%
    HALO annual revenue is higher than 80.07% of companies in Healthcare sector

    EPS

    EPS

    $3.43
    HALO annual earnings per share is $3.43

    EPS Analysts estimate

    $5.32
    HALO annual earnings per share is currently -35.47% lower than the consensus analysts' forecast

    EPS 1-year change

    +63.33%
    HALO annual earnings per share is up +63.33% year-on-year

    EPS Sector rank

    94.26%
    HALO annual earnings per share is higher than 94.26% of companies in Healthcare sector

    Profit

    Gross profit

    $855.91M
    HALO annual gross profit is $855.91 million

    Gross margin

    84.30%
    HALO annual gross profit margin is 84.30%

    Operating profit

    $551.48M
    HALO annual operating income is $551.48 million

    Operating margin

    54.32%
    HALO annual operating profit margin is 54.32%

    Net income

    $444.09M
    HALO annual net profit is $444.09 million

    Net margin

    43.74%
    HALO annual net profit margin is 43.74%

    Expenses

    Total expenses

    $463.85M
    HALO annual total expenses is $463.85 million

    Operating expenses

    $304.43M
    HALO annual total operating expenses is $304.43 million

    Cost of goods sold

    $159.42M
    HALO annual cost of goods sold is $159.42 million

    Selling, general & administrative expenses

    $154.34M
    HALO annual SGA is $154.34 million

    Depreciation and amortization

    $81.31M
    HALO annual depreciation & amortization is $81.31 million

    Interest expense

    $18.09M
    HALO annual interest expense is $18.09 million

    Income tax

    $113.04M
    HALO annual income tax is $113.04 million

    EBIT & EBITDA

    EBIT

    $575.23M
    HALO annual earnings before interest & taxes is $575.23 million

    EBITDA

    $656.54M
    HALO annual EBITDA is $656.54 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $2.06B
    HALO annual total assets is $2.06 billion

    Non current assets

    $978.14M
    HALO annual long term assets is $978.14 million

    Current assets

    $1.09B
    HALO annual total current assets is $1.09 billion

    Cash and cash equivalents

    $115.85M
    HALO annual cash & cash equivalents is $115.85 million

    Accounts receivable

    $296.94M
    HALO annual accounts receivable is $296.94 million

    Inventory

    $141.86M
    HALO annual inventory is $141.86 million

    Liabilities

    Total liabilities

    $1.70B
    HALO annual total liabilities is $1.70 billion

    Long term liabilities

    $1.56B
    HALO annual total long term liabilities is $1.56 billion

    Current liabilities

    $139.10M
    HALO annual total current liabilities is $139.10 million

    Accounts payable

    $10.25M
    HALO annual accounts payable is $10.25 million

    Debt

    Total debt

    $1.51B
    HALO annual total debt is $1.51 billion

    Total debt 1-year change

    +0.44%
    HALO annual total debt is up +0.44% year-on-year

    Long term debt

    $1.51B
    HALO annual long term debt is $1.51 billion

    Short term debt

    -
    HALO annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $363.82M
    HALO annual stockholders equity is $363.82 million

    Book value

    $363.82M
    HALO annual book value is $363.82 million

    Retained earnings

    $359.87M
    HALO annual retained earnings is $359.87 million

    Working capital

    $946.24M
    HALO annual working capital is $946.24 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $479.06M
    HALO annual cash flow from operations is $479.06 million

    Cash from operations 1-year change

    +23.29%
    HALO annual cash flow from operations is up +23.29% year-on-year

    Cash from investing

    -$262.72M
    HALO annual cash flow from investing activities is -$262.72 million

    Cash from investing 1-year change

    -171.1%
    HALO annual cash flow from investing activities is down -171.1% year-on-year

    Cash from financing

    -$218.86M
    HALO annual cash flow from financing activities is -$218.86 million

    Cash from financing 1-year change

    +46.36%
    HALO annual cash flow from financing activities is up +46.36% year-on-year

    CAPEX

    CAPEX

    $10.70M
    HALO annual capital expenditures is $10.70 million

    CAPEX 1-year change

    -30.06%
    HALO annual capital expenditures is down -30.06% year-on-year

    Free Cash Flow

    Free cash flow

    $468.37M
    HALO annual free cash flow is $468.37 million

    Free cash flow 1-year change

    +25.47%
    HALO annual free cash flow is up +25.47% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    84.30%
    HALO annual gross profit margin is 84.30%

    Operating margin

    54.32%
    HALO annual operating profit margin is 54.32%

    Net margin

    43.74%
    HALO annual net profit margin is 43.74%

    ROA & ROE

    ROA

    23.39%
    HALO annual return on assets is 23.39%

    ROE

    198.42%
    HALO annual return on equity is 198.42%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    15.20
    HALO price to earnings ratio is 15.20

    PE ratio Sector rank

    29.58%
    HALO price to earnings ratio is higher than 29.58% of companies in Healthcare sector

    PB Ratio

    PB ratio

    14.60
    HALO price to book ratio is 14.60

    PB ratio Sector rank

    93.05%
    HALO price to book ratio is higher than 93.05% of companies in Healthcare sector

    PS Ratio

    PS ratio

    6.49
    HALO price to sales ratio is 6.49

    PS ratio Sector rank

    68.5%
    HALO price to sales ratio is higher than 68.5% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $8.37B
    HALO enterprise value is $8.37 billion

    Enterprise value Sector rank

    90.5%
    HALO enterprise value is higher than 90.5% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    11.88
    HALO EV/EBITDA is 11.88

    EV/EBITDA Sector rank

    84.96%
    HALO EV/EBITDA is higher than 84.96% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.80
    HALO annual current ratio is 7.80

    Quick ratio

    6.78
    HALO annual quick ratio is 6.78

    Leverage

    Debt to equity

    4.14
    HALO annual debt to equity ratio is 4.14

    Interest coverage ratio

    31.79
    HALO annual interest coverage ratio is 31.79

    Risk & Stability

    Piotroski F-Score

    7
    HALO piotroski f-score is 7

    Altman Z-Score

    4.69
    HALO altman z-score is 4.69

    Analyst ratings

    Recent major analysts updates

    May 29, 25 HC Wainwright & Co.
    Buy
    May 14, 25 Morgan Stanley
    Equal-Weight
    May 13, 25 Leerink Partners
    Underperform
    May 7, 25 Wells Fargo
    Equal-Weight
    Apr 25, 25 HC Wainwright & Co.
    Buy
    Apr 21, 25 JP Morgan
    Neutral
    Mar 6, 25 HC Wainwright & Co.
    Buy
    Feb 20, 25 Benchmark
    Buy
    Feb 19, 25 HC Wainwright & Co.
    Buy
    Feb 4, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with HALO included

    Mid cap stocks
    US stocks
    High Piotroski score stocks
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Halozyme Therapeutics, Inc.?
    • Does Halozyme Therapeutics, Inc. pay dividends?
    • What sector is Halozyme Therapeutics, Inc. in?
    • What industry is Halozyme Therapeutics, Inc. in?
    • What country is Halozyme Therapeutics, Inc. based in?
    • When did Halozyme Therapeutics, Inc. go public?
    • Is Halozyme Therapeutics, Inc. in the S&P 500?
    • Is Halozyme Therapeutics, Inc. in the NASDAQ 100?
    • Is Halozyme Therapeutics, Inc. in the Dow Jones?
    • When was Halozyme Therapeutics, Inc.'s last earnings report?
    • When does Halozyme Therapeutics, Inc. report earnings?

    What is the ticker symbol for Halozyme Therapeutics, Inc.?

    The ticker symbol for Halozyme Therapeutics, Inc. is NASDAQ:HALO

    Does Halozyme Therapeutics, Inc. pay dividends?

    No, Halozyme Therapeutics, Inc. does not pay dividends

    What sector is Halozyme Therapeutics, Inc. in?

    Halozyme Therapeutics, Inc. is in the Healthcare sector

    What industry is Halozyme Therapeutics, Inc. in?

    Halozyme Therapeutics, Inc. is in the Biotechnology industry

    What country is Halozyme Therapeutics, Inc. based in?

    Halozyme Therapeutics, Inc. is headquartered in United States

    When did Halozyme Therapeutics, Inc. go public?

    Halozyme Therapeutics, Inc.'s initial public offering (IPO) was on March 16, 2004

    Is Halozyme Therapeutics, Inc. in the S&P 500?

    No, Halozyme Therapeutics, Inc. is not included in the S&P 500 index

    Is Halozyme Therapeutics, Inc. in the NASDAQ 100?

    No, Halozyme Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Halozyme Therapeutics, Inc. in the Dow Jones?

    No, Halozyme Therapeutics, Inc. is not included in the Dow Jones index

    When was Halozyme Therapeutics, Inc.'s last earnings report?

    Halozyme Therapeutics, Inc.'s most recent earnings report was on May 6, 2025

    When does Halozyme Therapeutics, Inc. report earnings?

    The next expected earnings date for Halozyme Therapeutics, Inc. is August 6, 2025
    On this page